RxDoctor Payments Data

Howard Cohen

Pain Medicine · Dallas, TXNPI 1962516112

Payments from drug & device makers

$5,534in general payments, 2019–2025

Across 266 payments — averaging $20.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$504
  • Teva Pharmaceuticals USA, Inc.$484
  • Otsuka America Pharmaceutical, Inc.$298
  • Avanir Pharmaceuticals, Inc.$285
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$230
  • plus $2K from 37 others

What the payments were for

  • Food & beverage$5,534100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,534 in reported general payments places this provider in the 60th percentile of 583 pain medicine providers in Texas.

See all pain medicine providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Desvenlafaxine Succinate ErDesvenlafaxine Succinate33$1,195
Gabapentin33$445
Ondansetron OdtOndansetron18$208
Tizanidine Hcl16$206
Venlafaxine Hcl ErVenlafaxine Hcl14$150
Quetiapine Fumarate13$118
Lithium Carbonate11$93
Escitalopram Oxalate28$92
Celecoxib11$46

Paid to pharmacies, not to this prescriber.

Other pain medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →